Document:

Consent and Seventh Amendment to Credit Agreement

 Exhibit 10.8(g) 
 EXECUTION COPY 
 CONSENT AND SEVENTH AMENDMENT TO CREDIT AGREEMENT 
 CONSENT AND SEVENTH AMENDMENT TO CREDIT AGREEMENT (this “Amendment”), dated as of October 21, 2008, among ADDUS HEALTHCARE, INC.,
an Illinois corporation (“Borrower”), the other persons signatory hereto as “Loan Parties”, FREEPORT FINANCIAL LLC, a Delaware limited liability company (“Agent”) and the Lenders signatory hereto. Terms
not defined herein have the meanings given to them in the Credit Agreement (as hereinafter defined). 
 RECITALS 
 A. Borrower, the Loan Parties, the Lenders signatory thereto and Agent are party to that certain Credit Agreement dated as of September 19, 2006 (as
amended by that certain Consent and First Amendment to Credit Agreement dated as of July 29, 2007, that certain Consent and Second Amendment to Credit Agreement dated as of October 15, 2007, that certain Consent and Third Amendment to
Credit Agreement dated as of November 13, 2007, that certain Consent and Fourth Amendment to Credit Agreement dated as of April 1, 2008, that certain Consent and Fifth Amendment to Credit Agreement dated as of June 9, 2008, that
certain Consent and Sixth Amendment to Credit Agreement dated as of September 25, 2008 and as further amended, restated or otherwise modified including by this Amendment, the “Credit Agreement”). 
 B. Borrower, the Loan Parties, the Lenders and Agent are entering into this Amendment to amend certain provisions of the Credit Agreement. 
 C. Agent, Lenders and the Loan Parties are willing to enter into this Amendment upon the terms and conditions set forth below. 
 NOW THEREFORE, in consideration of the matters set forth in the recitals and the covenants and provisions herein set forth, and other valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 
 AGREEMENT 

 Section 1. Definitions. Capitalized terms used herein and not otherwise defined herein shall have the meanings ascribed
thereto in the Credit Agreement. 
 Section 2. Consent. Borrower, Agent and the Lenders hereby (A) consent to the assignment
of certain Loans pursuant to the Assignment Agreement (the “Seventh Amendment Assignment”) attached to this Amendment as Exhibit A notwithstanding the minimum assignment provisions of Section 9.1(a) of the Credit
Agreement; and (B) consent to the drawing of all remaining Delayed Draw Term Loan Commitments immediately prior to the Seventh Amendment Effective Date notwithstanding the conditions to borrowing set forth in Section 2.1(a)(iv) of
the Credit Agreement have not been met; provided that, notwithstanding the terms set forth in Section 2.1(a)(iii) of the Credit Agreement with respect to the use of proceeds of the 

 
Delayed Draw Term Loans, the proceeds of the Delayed Draw Term Loans so borrowed are immediately applied to pay the amendment fee pursuant to
Section 5.4 hereof and repay the outstanding principal amount of the Revolving Loans. 
 Section 3. Amendment to the Credit
Agreement. As of the Seventh Amendment Effective Date, the Credit Agreement is hereby amended as follows: 
 3.1. Section 1.1
of the Credit Agreement is hereby amended by adding the following new definitions thereto: 
 Seventh Amendment means that certain
Consent and Seventh Amendment to Credit Agreement dated as of October 21, 2008 among the Loan Parties, Agent and the Lenders. 
 Seventh Amendment Assignment has the meaning set forth in the Seventh Amendment. 
 Seventh Amendment Effective Date
has the meaning set forth in the Seventh Amendment. 
 Seventh Amendment Reaffirmation of Collateral Documents means the Consent and
Reaffirmation (Seventh Amendment), dated as of October 21, 2008 of the Loan Parties signatory thereto, in respect of the Collateral Documents. 
 3.2. On the Seventh Amendment Effective Date, Section 2.1(a)(v) of the Credit Agreement shall be amended and restated in its entirety and replaced with the following new Section 2.1(a)(v): 
 (v) Borrower shall repay the Term Loans through periodic payments on the dates and in the amounts indicated below (“Scheduled
Installments”), and in any event the entire remaining principal balance shall be repaid on the Commitment Termination Date. 
 Term Loan 
  

			
	 Date
	  	Scheduled Installment
	 December 31, 2008
	  	$1,662,500
		
	 March 31, 2009
	  	$1,662,500
		
	 June 30, 2009
	  	$1,662,500
		
	 September 30, 2009
	  	$1,662,500
		
	 December 31, 2009
	  	$2,100,000
		
	 March 31, 2010
	  	$2,100,000
		
	 June 30, 2010
	  	$2,100,000
		
	 September 30, 2010
	  	$2,100,000
		
	 December 31, 2010
	  	$2,537,500
		
	 March 31, 2011
	  	$2,537,500
		
	 June 30, 2011
	  	$2,537,500
		
	 September 19, 2011
	  	$32,368,500 or the outstanding principal balance of
Term Loans outstanding on such date

  

 2 

 The above scheduled installment amounts reflect the incurrence by the Borrower of the Delayed Draw Term Loans funded as
of the Seventh Amendment Effective Date. The final installment payment shall in all events equal the entire remaining principal balance of the Term Loan (including any remaining principal balance of such Delayed Draw Term Loans). Amounts borrowed
under this Section 2.1(a) and repaid may not be reborrowed. 
 At the request of the applicable Lender, the Term Loans shall be evidenced by
promissory notes substantially in the form of Exhibit 2.1(a) (as amended, modified, extended, substituted or replaced from time to time, each a “Term Note” and, collectively, the “Term Notes”), and Borrower
shall execute and deliver a Term Note to each such Term Lender. Each Term Note shall represent the obligation of Borrower to pay the amount of the applicable Term Lender’s Term Loan Commitment, together with interest thereon.” 

3.3. On the Seventh Amendment Effective Date, Section 7.1(d) of the Credit Agreement shall be amended by replacing the Leverage Ratios
currently referenced in such Section (i) for the Fiscal Quarters ending December 31, 2008 and March 31, 2009 with references in each case to 4.25:1.00; (ii) for the Fiscal Quarter ending June 30, 2009 with a reference to
4:00:1.00; and (iii) for the Fiscal Quarter ending September 30, 2009 with a reference to 3.75:1.00. 
 Section 4.
Representations and Warranties. To induce Agent and Lenders to execute this Amendment, each Loan Party hereby represents and warrants to Agent and Lenders as follows: 
 (a) the execution, delivery and performance of this Amendment has been duly authorized by all requisite action of each Loan Party thereto, and this Amendment constitutes the legal, valid and binding obligation of such
Person, enforceable against such Person in accordance with its terms, subject to bankruptcy, insolvency and similar laws affecting the enforceability of creditors’ rights generally and to general principles of equity; and 
 (b) each of the representations and warranties in the Credit Agreement are true and correct in all material respects with the same effect as though made on and as of the
date hereof (except, in each case, to the extent stated to relate to an earlier date, in which case such representation or warranty shall have been true and correct on and as of such earlier date) and no Event of Default or Default exists thereunder
or would exist after giving effect to this Amendment. 
 Section 5. Conditions Precedent. This Amendment shall be effective as of
the date first set forth above, subject to the satisfaction of the following conditions precedent (the date of such satisfaction being the “Seventh Amendment Effective Date”): 
 5.1. Execution and Delivery. Borrower, each of the other Loan Parties, Agent, the Requisite Lenders, each holder of Delayed Draw Term Loans and
the Supermajority Revolving Lenders shall have executed and delivered this Agreement and each Loan Party shall have executed and delivered the Consent and Reaffirmation in the form of Exhibit B attached hereto. 
  

 3 

 5.2. Assignment Agreements. The Seventh Amendment Assignment shall be effective and the settlement
of amounts due pursuant thereto shall have occurred. 
 5.3. Delayed Draw Term Loans. The Lenders holding Delayed Draw Term Loan
Commitments shall have funded all such remaining Commitments and the proceeds of such borrowing shall have been immediately applied to pay the amendment fee pursuant to Section 5.4 hereof and repay the outstanding principal amount of the
Revolving Loans. 
 5.4. Amendment Fee. Borrower shall have paid to Agent for the benefit of each Lender an amendment fee in an amount
equal to $271,991.25 which amount shall be payable to each such Lender based on such Lender’s Pro Rata Share of such amount in each case immediately prior to giving effect to the Seventh Amendment Assignment but after giving effect to the
drawing of the Delayed Draw Term Loans referenced in Section 5.3 of this Amendment. 
 5.5. No Defaults. After giving effect to
this Amendment, no Event of Default or Default under the Credit Agreement shall have occurred and be continuing. 
 5.6. Representations
and Warranties. After giving effect to this Amendment, the representations and warranties of the Loan Parties contained in this Amendment, the Credit Agreement and the other Loan Documents shall be true and correct in all material respects as of
the Seventh Amendment Effective Date, with the same effect as though made on such date, except to the extent that any such representation or warranty relates to an earlier date, in which case such representation or warranty shall be true and correct
in all material respects as of such earlier date. 
 5.7. Fees. Borrower shall have paid all reasonable and documented costs, fees and
expenses (including, without limitation, reasonable legal fees and expenses of Winston & Strawn LLP) of Agent. 
 5.8. Other
Matters. Agent shall have received such other instruments and documents as Agent or the Requisite Lenders may reasonably request in connection with the execution of this Amendment, and all such instruments and documents shall be reasonably
satisfactory in form and substance to Agent. 
 Section 6. Miscellaneous. 
 6.1. Effect of Amendment. The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy
of Agent or any Lender under the Credit Agreement or any Loan Document, or constitute a waiver of any provision of the Credit Agreement or any Loan Document, except as specifically set forth herein. 
  

 4 

 6.2. Counterparts. This Amendment may be executed in any number of counterparts and by the
different parties on separate counterparts, and each such counterpart shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument. Delivery of the executed counterpart of this Amendment by
telecopy or electronic mail shall be as effective as delivery of a manually executed counterpart to this Amendment. 
 6.3.
Severability. The illegality or unenforceability of any provision of this Amendment or any instrument or agreement required hereunder shall not in any way affect or impair the legality or enforceability of the remaining provisions of this
Amendment or any instrument or agreement required hereunder. 
 6.4. Captions. Section captions used in this Amendment are for
convenience only, and shall not affect the construction of this Amendment. 
 6.5. Entire Agreement. This Amendment embodies the
entire agreement and understanding among the parties hereto and supersedes all prior or contemporaneous agreements and understandings of such Persons, verbal or written, relating to the subject matter hereof. 
 6.6. References. Any reference to the Credit Agreement contained in any notice, request, certificate, or other document executed concurrently with
or after the execution and delivery of this Amendment shall be deemed to include this Amendment unless the context shall otherwise require. Reference in any of this Amendment, the Credit Agreement or any other Loan Document to the Credit Agreement
shall be a reference to the Credit Agreement as amended hereby and as further amended, modified, restated, supplemented or extended from time to time. 
 Section 7. Governing Law. THIS AMENDMENT SHALL BE A CONTRACT MADE UNDER AND GOVERNED BY THE INTERNAL LAWS OF THE STATE OF ILLINOIS APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH
STATE, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES. 
 [signature pages follow] 
  

 5 

 Witness the due execution hereof by the respective duly authorized officers of the undersigned as of the
date first above written. 
  

			
	ADDUS HOLDING CORPORATION
		
	By:	 	 /s/ Simon Bachleda

	Name:	 	Simon Bachleda
	Title:	 	Vice President and Secretary

  

			
	ADDUS HEALTHCARE, INC.
	
	FORT SMITH HOME HEALTH AGENCY, INC.
	
	LITTLE ROCK HOME HEALTH AGENCY, INC.
	
	LOWELL HOME HEALTH AGENCY, INC.
	
	PHC ACQUISITION CORPORATION
	
	PROFESSIONAL RELIABLE NURSING SERVICE, INC.
	
	BENEFITS ASSURANCE CO., INC.
		
	By:	 	 /s/ Frank Leonard

	Name:	 	Frank Leonard
	Title:	 	Chief Financial Officer and Secretary

			
	FREEPORT FINANCIAL LLC, as Agent
		
	By:	 	 /s/ Chad Blakeman

	Title:	 	 Sr. Managing Director

	
	FREEPORT LOAN FUND LLC, as a Lender
		
	By:	 	 /s/ Chad Blakeman

	Title:	 	 Sr. Managing Director

	
	FREEPORT OFFSHORE LOAN FUND LLC, as a Lender
		
	By:	 	 /s/ Chad Blakeman

	Title:	 	 Sr. Managing Director

	
	FREEPORT LOAN TRUST 2006-1, as a Lender
		
	By:	 	 /s/ Chad Blakeman

	Title:	 	 Sr. Managing Director

			
	 FIFTH THIRD BANK, CHICAGO
 (A
Michigan Banking Company)

		
	By:	 	 /s/ Michael E. May

	Name:	 	 Michael E. May

	Title:	 	 Vice President

			
	CF BLACKBURN LLC
		
	By:	 	  

	Name:	 	  

	Title:	 	  

 EXHIBIT A 
 ASSIGNMENT AGREEMENT 
 This Assignment Agreement (this “Agreement”) is made as of
October 21, 2008 by and between FREEPORT LOAN FUND LLC (“Assignor Lender”) and FIFTH THIRD BANK, CHICAGO (A MICHIGAN BANKING COMPANY) (“Assignee Lender”). All capitalized terms used in this Agreement and not
otherwise defined herein will have the respective meanings set forth in the Credit Agreement as hereinafter defined. 
 RECITALS:

 WHEREAS, Addus HealthCare, Inc., an Illinois corporation, (“Borrower”), Freeport Financial LLC, as agent
(“Agent”), Assignor Lender and other Persons signatory thereto as Lenders have entered into that certain Credit Agreement dated as of September 19, 2006 (as amended, restated, supplemented or otherwise modified from time to
time, the “Credit Agreement”) pursuant to which Assignor Lender has agreed to make certain Loans to, and incur certain Letter of Credit Obligations for, Borrower; 
 WHEREAS, Assignor Lender desires to assign to Assignee Lender a portion of its interest in the Loans (as described below), the Letter of Credit
Obligations and the Collateral and to delegate to Assignee Lender a portion of its Commitments and other duties with respect to such Loans, Letter of Credit Obligations and Collateral; 
 WHEREAS, Assignee Lender desires to continue as a Lender under the Credit Agreement and to accept such assignment and delegation from Assignor Lender;
and 
 NOW, THEREFORE, in consideration of the premises and the agreements, provisions, and covenants herein contained, Assignor Lender and
Assignee Lender agree as follows: 
 1. ASSIGNMENT, DELEGATION, AND ACCEPTANCE 
 1.1 Assignment. Assignor Lender hereby transfers and assigns to Assignee Lender, without recourse and without representations or warranties of any kind
(except as set forth in Section 3.2), such percentage of Assignor Lender’s right, title, and interest in the Delayed Draw Term Loan Commitment, Loan Documents and the Collateral, as of the Effective Date (as hereinafter defined), as
follows: 
  

							
	 Assignee Lender’s Loans
	  	 Commitment Amount
	  	 Pro Rata Share
	 
	 Delayed Draw Term Loan Commitment
	  	$	 960,000.00	  	34.28571428	% 

 1.2 Delegation. Assignor Lender hereby irrevocably assigns and delegates to Assignee Lender a portion of
its Commitments and its other duties and obligations as a Lender under the Loan Documents equivalent to the Pro Rata Share set forth above. 
 1.3 Acceptance by Assignee Lender. By its execution of this Agreement, Assignee Lender irrevocably purchases, assumes and accepts such assignment and delegation and agrees to be a Lender with respect to the delegated interest under the Loan
Documents and to be bound by the terms and conditions thereof. By its execution of this Agreement, Assignor Lender agrees, to the extent provided herein, to relinquish its rights and be released from its obligations and duties under the Credit
Agreement. 
 1.4 Effective Date. Such assignment and delegation by Assignor Lender and acceptance by Assignee Lender will be effective and
Assignee Lender will become a Lender under the Loan Documents as of the date of this Agreement (“Effective Date”). Interest and Fees accrued prior to the Effective Date are for the account of Assignor Lender, and Interest and Fees
accrued from and after the Effective Date are for the account of Assignee Lender. The Assignor Lender hereby agrees to waive payment of the assignment fee required by the Credit Agreement for this assignment. This is a one-time waiver and should not
be construed as creating a course of conduct. 
 2. INITIAL PAYMENT AND DELIVERY OF NOTES 
 2.1 [Reserved] 
 2.2 [Reserved] 

2.3 Execution and Delivery of Notes. Assignor Lender will deliver to Agent the Notes previously delivered to Assignor Lender for redelivery to
Borrower and, if requested by Assignee Lender, Agent will obtain from Borrower for delivery to Assignor Lender and Assignee Lender, new executed Notes evidencing Assignee Lender’s and Assignor Lender’s respective Pro Rata Shares in the
Loans after giving effect to the assignment described in Section 1. Each new Note will be issued in the aggregate maximum principal amount of the applicable Commitment of the Lender to whom such Note is issued. 
 3. REPRESENTATIONS, WARRANTIES AND COVENANTS 
 3.1 Assignee Lender’s Representations, Warranties and Covenants. Assignee Lender hereby represents, warrants, and covenants the following to Assignor Lender and Agent: 
 (a) This Agreement is a legal, valid, and binding agreement of Assignee Lender, enforceable according to its terms; 
 (b) The execution and performance by Assignee Lender of its duties and obligations under this Agreement and the Loan Documents will not
require any registration with, notice to, or consent or approval by any Governmental Authority; 

 (c) Assignee Lender is familiar with transactions of the kind and scope reflected in the
Loan Documents and in this Agreement; 
 (d) Assignee Lender has made its own independent investigation and appraisal of the
financial condition and affairs of each Loan Party, has conducted its own evaluation of the Loans and Letter of Credit Obligations, the Loan Documents and each Loan Party’s creditworthiness, has made its decision to become a Lender to Borrower
under the Credit Agreement independently and without reliance upon Assignor Lender or Agent, and will continue to do so; 
 (e) Assignee Lender is entering into this Agreement in the ordinary course of its business, and is acquiring its interest in the Loans and Letter of Credit Obligations for its own account and not with a view to or for sale in connection
with any subsequent distribution; provided, however, that at all times the distribution of Assignee Lender’s property shall, subject to the terms of the Credit Agreement, be and remain within its control; 
 (f) No future assignment or participation granted by Assignee Lender pursuant to Section 9.1 of the Credit Agreement will require
Assignor Lender, Agent, or Borrower to file any registration statement with the Securities and Exchange Commission or to apply to qualify under the blue sky laws of any state; 
 (g) Assignee Lender has no loans (other than the Loans) to, written or oral agreements with, or equity or other ownership interest in any
Loan Party; 
 (h) Assignee Lender will not enter into any written or oral agreement with, or acquire any equity or other
ownership interest in, any Loan Party without the prior written consent of Agent; and 
 (i) As of the Effective Date,
Assignee Lender (i) is entitled to receive payments of principal and interest in respect of the Obligations without deduction for or on account of any taxes imposed by the United States of America or any political subdivision thereof,
(ii) is not subject to capital adequacy or similar requirements under Section 2.8(a) of the Credit Agreement, (iii) does not require the payment of any increased costs under Section 2.8(b) of the Credit Agreement, and
(iv) is not unable to fund LIBOR Loans under Section 2.8(b) of the Credit Agreement, and Assignee Lender will indemnify Agent from and against all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, or
expenses that result from Assignee Lender’s failure to fulfill its obligations under the terms of Section 2.9(c) of the Credit Agreement or from any other inaccuracy in the foregoing. 

 3.2 Assignor Lender’s Representations, Warranties and Covenants. Assignor Lender hereby represents,
warrants and covenants the following to Assignee Lender: 
 (a) Assignor Lender is the legal and beneficial owner of the
Delayed Draw Term Loan Commitment; 
 (b) This Agreement is a legal, valid and binding agreement of Assignor Lender,
enforceable according to its terms; 
 (c) The execution and performance by Assignor Lender of its duties and obligations
under this Agreement and the Loan Documents will not require any registration with, notice to or consent or approval by any Governmental Authority; 
 (d) Assignor Lender has full power and authority, and has taken all action necessary to execute and deliver this Agreement and to fulfill the obligations hereunder and to consummate the transactions contemplated
hereby; 
 (e) Assignor Lender is the legal and beneficial owner of the interests being assigned hereby, free and clear of any
adverse claim, lien, encumbrance, security interest, restriction on transfer, purchase option, call or similar right of a third party; and 
 (f) This Assignment by Assignor Lender to Assignee Lender complies, in all material respects, with the terms of the Loan Documents. 
 4. LIMITATIONS OF LIABILITY 
 Neither Assignor Lender (except as provided in Section 3.2) nor
Agent makes any representations or warranties of any kind, nor assumes any responsibility or liability whatsoever, with regard to (a) the Loan Documents or any other document or instrument furnished pursuant thereto or the Loans, Letter of
Credit Obligations or other Obligations, (b) the creation, validity, genuineness, enforceability, sufficiency, value or collectibility of any of them, (c) the amount, value or existence of the Collateral, (d) the perfection or
priority of any Lien upon the Collateral, or (e) the financial condition of any Loan Party or other obligor or the performance or observance by any Loan Party of its obligations under any of the Loan Documents. Neither Assignor Lender nor Agent
has or will have any duty, either initially or on a continuing basis, to make any investigation, evaluation, appraisal of, or any responsibility or liability with respect to the accuracy or completeness of, any information provided to Assignee
Lender which has been provided to Assignor Lender or Agent by any Loan Party. Nothing in this Agreement or in the Loan Documents shall impose upon the Assignor Lender or Agent any fiduciary relationship in respect of the Assignee Lender. 

 5. FAILURE TO ENFORCE 
 No failure or delay on the part of Agent or Assignor Lender in the exercise of any power, right, or privilege hereunder or under any Loan Document will impair such power, right, or privilege or be construed to be a
waiver of any default or acquiescence therein. No single or partial exercise of any such power, right, or privilege will preclude further exercise thereof or of any other right, power, or privilege. All rights and remedies existing under this
Agreement are cumulative with, and not exclusive of, any rights or remedies otherwise available. 
 6. NOTICES 
 Unless otherwise specifically provided herein, any notice or other communication required or permitted to be given will be in writing and addressed to
the respective party as set forth below its signature hereunder, or to such other address as the party may designate in writing to the other. 
 7. AMENDMENTS AND WAIVERS 
 No amendment, modification, termination, or waiver of any provision of this Agreement will be effective
without the written concurrence of Assignor Lender, Agent and Assignee Lender. 
 8. SEVERABILITY 
 Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law. In the event
any provision of this Agreement is or is held to be invalid, illegal, or unenforceable under applicable law, such provision will be ineffective only to the extent of such invalidity, illegality, or unenforceability, without invalidating the
remainder of such provision or the remaining provisions of the Agreement. In addition, in the event any provision of or obligation under this Agreement is or is held to be invalid, illegal, or unenforceable in any jurisdiction, the validity,
legality, and enforceability of the remaining provisions or obligations in any other jurisdictions will not in any way be affected or impaired thereby. 
 9. SECTION TITLES 
 Section and Subsection titles in this Agreement are included for convenience of
reference only, do not constitute a part of this Agreement for any other purpose, and have no substantive effect. 
 10. SUCCESSORS AND
ASSIGNS 
 This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.

 11. APPLICABLE LAW 
 THIS
AGREEMENT WILL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND PERFORMED IN THAT STATE. 

 12. COUNTERPARTS 
 This Agreement and any amendments, waivers, consents, or supplements may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which, when so executed and
delivered, will be deemed an original and all of which shall together constitute one and the same instrument. 
 [Signature page follows]

 IN WITNESS WHEREOF, this Agreement has been duly executed as of the date first written above. 

 

									
	ASSIGNEE LENDER:	 		 	ASSIGNOR LENDER:
			
	FIFTH THIRD BANK, CHICAGO	 		 	FREEPORT LOAN FUND LLC
	(A MICHIGAN BANKING COMPANY)	 		 	
					
	By:	 	 	 		 	By:	 	 
	Title:	 	 	 		 	Title:	 	 
			
	Notice Address:	 		 	Notice Address:
			
	222 South Riverside Plaza	 		 	500 West Madison Street, Suite 7200
	33rd Floor, MD GRVR3I	 		 	Chicago, Illinois 60661
	Chicago, IL 60606	 		 	Attn: Addus HealthCare Inc. Account Officer
	Attn: Gregory H. Bork	 		 	Fax: (312) 281-4646
	Fax: (312) 704-4374	 		 	

 ASSIGNMENT AGREEMENT 
 This Assignment Agreement (this “Agreement”) is made as of October 21, 2008 by and between FREEPORT OFFSHORE LOAN FUND LLC (“Assignor Lender”) and FIFTH THIRD BANK, CHICAGO (A
MICHIGAN BANKING COMPANY) (“Assignee Lender”). All capitalized terms used in this Agreement and not otherwise defined herein will have the respective meanings set forth in the Credit Agreement as hereinafter defined. 
 RECITALS: 
 WHEREAS, Addus HealthCare,
Inc., an Illinois corporation, (“Borrower”), Freeport Financial LLC, as agent (“Agent”), Assignor Lender and other Persons signatory thereto as Lenders have entered into that certain Credit Agreement dated as of
September 19, 2006 (as amended, restated, supplemented or otherwise modified from time to time, the “Credit Agreement”) pursuant to which Assignor Lender has agreed to make certain Loans to, and incur certain Letter of Credit
Obligations for, Borrower; 
 WHEREAS, Assignor Lender desires to assign to Assignee Lender a portion of its interest in the Loans (as
described below), the Letter of Credit Obligations and the Collateral and to delegate to Assignee Lender a portion of its Commitments and other duties with respect to such Loans, Letter of Credit Obligations and Collateral; 
 WHEREAS, Assignee Lender desires to continue as a Lender under the Credit Agreement and to accept such assignment and delegation from Assignor Lender;
and 
 NOW, THEREFORE, in consideration of the premises and the agreements, provisions, and covenants herein contained, Assignor Lender and
Assignee Lender agree as follows: 
 1. ASSIGNMENT, DELEGATION, AND ACCEPTANCE 
 1.1 Assignment. Assignor Lender hereby transfers and assigns to Assignee Lender, without recourse and without representations or warranties of any kind
(except as set forth in Section 3.2), such percentage of Assignor Lender’s right, title, and interest in the Revolving Loan Commitment, Loan Documents and the Collateral, as of the Effective Date (as hereinafter defined), as
follows: 
  

							
	 Assignee Lender’s Loans
	  	 Commitment Amount
	  	 Pro Rata Share
	 
	 Revolving Loan Commitment
	  	$	4,040,000.00	  	23.08571428	% 

 On the Effective Date the funded portion of the Revolving Loan Commitment so assigned is equal to
$1,731,429.00 (the “Funded Revolving Loan Amount”). 
 1.2 Delegation. Assignor Lender hereby irrevocably assigns and
delegates to Assignee Lender a portion of its Commitments and its other duties and obligations as a Lender under the Loan Documents equivalent to the Pro Rata Share set forth above. 

 1.3 Acceptance by Assignee Lender. By its execution of this Agreement, Assignee Lender irrevocably
purchases, assumes and accepts such assignment and delegation and agrees to be a Lender with respect to the delegated interest under the Loan Documents and to be bound by the terms and conditions thereof. By its execution of this Agreement, Assignor
Lender agrees, to the extent provided herein, to relinquish its rights and be released from its obligations and duties under the Credit Agreement. 
 1.4 Effective Date. Such assignment and delegation by Assignor Lender and acceptance by Assignee Lender will be effective and Assignee Lender will become a Lender under the Loan Documents as of the date of this Agreement (“Effective
Date”) and upon payment of the Assigned Amount (as such term is defined below). Interest and Fees accrued prior to the Effective Date are for the account of Assignor Lender, and Interest and Fees accrued from and after the Effective Date
are for the account of Assignee Lender. The Assignor Lender hereby agrees to waive payment of the assignment fee required by the Credit Agreement for this assignment. This is a one-time waiver and should not be construed as creating a course of
conduct. 
 2. INITIAL PAYMENT AND DELIVERY OF NOTES 
 2.1 Payment of the Assigned Amount. Assignee Lender will pay to Assignor Lender, in immediately available funds, not later than 4:00 p.m. (Chicago time) on the Effective Date, an amount equal to the Funded Revolving
Loan Amount (the “Assigned Amount”). 
 2.2 [Reserved] 
 2.3 Execution and Delivery of Notes. Following payment of the Assigned Amount, Assignor Lender will deliver to Agent the Notes previously delivered to
Assignor Lender for redelivery to Borrower and, if requested by Assignee Lender, Agent will obtain from Borrower for delivery to Assignor Lender and Assignee Lender, new executed Notes evidencing Assignee Lender’s and Assignor Lender’s
respective Pro Rata Shares in the Loans after giving effect to the assignment described in Section 1. Each new Note will be issued in the aggregate maximum principal amount of the applicable Commitment of the Lender to whom such Note is
issued. 
 3. REPRESENTATIONS, WARRANTIES AND COVENANTS 
 3.1 Assignee Lender’s Representations, Warranties and Covenants. Assignee Lender hereby represents, warrants, and covenants the following to Assignor Lender and Agent: 
 (a) This Agreement is a legal, valid, and binding agreement of Assignee Lender, enforceable according to its terms; 
 (b) The execution and performance by Assignee Lender of its duties and obligations under this Agreement and the Loan Documents will not
require any registration with, notice to, or consent or approval by any Governmental Authority; 

 (c) Assignee Lender is familiar with transactions of the kind and scope reflected in the
Loan Documents and in this Agreement; 
 (d) Assignee Lender has made its own independent investigation and appraisal of the
financial condition and affairs of each Loan Party, has conducted its own evaluation of the Loans and Letter of Credit Obligations, the Loan Documents and each Loan Party’s creditworthiness, has made its decision to become a Lender to Borrower
under the Credit Agreement independently and without reliance upon Assignor Lender or Agent, and will continue to do so; 
 (e) Assignee Lender is entering into this Agreement in the ordinary course of its business, and is acquiring its interest in the Loans and Letter of Credit Obligations for its own account and not with a view to or for sale in connection
with any subsequent distribution; provided, however, that at all times the distribution of Assignee Lender’s property shall, subject to the terms of the Credit Agreement, be and remain within its control; 
 (f) No future assignment or participation granted by Assignee Lender pursuant to Section 9.1 of the Credit Agreement will require
Assignor Lender, Agent, or Borrower to file any registration statement with the Securities and Exchange Commission or to apply to qualify under the blue sky laws of any state; 
 (g) Assignee Lender has no loans (other than the Loans) to, written or oral agreements with, or equity or other ownership interest in any
Loan Party; 
 (h) Assignee Lender will not enter into any written or oral agreement with, or acquire any equity or other
ownership interest in, any Loan Party without the prior written consent of Agent; and 
 (i) As of the Effective Date,
Assignee Lender (i) is entitled to receive payments of principal and interest in respect of the Obligations without deduction for or on account of any taxes imposed by the United States of America or any political subdivision thereof,
(ii) is not subject to capital adequacy or similar requirements under Section 2.8(a) of the Credit Agreement, (iii) does not require the payment of any increased costs under Section 2.8(b) of the Credit Agreement, and
(iv) is not unable to fund LIBOR Loans under Section 2.8(b) of the Credit Agreement, and Assignee Lender will indemnify Agent from and against all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, or
expenses that result from Assignee Lender’s failure to fulfill its obligations under the terms of Section 2.9(c) of the Credit Agreement or from any other inaccuracy in the foregoing. 

 3.2 Assignor Lender’s Representations, Warranties and Covenants. Assignor Lender hereby represents,
warrants and covenants the following to Assignee Lender: 
 (a) Assignor Lender is the legal and beneficial owner of the
Assigned Amount; 
 (b) This Agreement is a legal, valid and binding agreement of Assignor Lender, enforceable according to
its terms; 
 (c) The execution and performance by Assignor Lender of its duties and obligations under this Agreement and the
Loan Documents will not require any registration with, notice to or consent or approval by any Governmental Authority; 
 (d)
Assignor Lender has full power and authority, and has taken all action necessary to execute and deliver this Agreement and to fulfill the obligations hereunder and to consummate the transactions contemplated hereby; 
 (e) Assignor Lender is the legal and beneficial owner of the interests being assigned hereby, free and clear of any adverse claim, lien,
encumbrance, security interest, restriction on transfer, purchase option, call or similar right of a third party; and 
 (f)
This Assignment by Assignor Lender to Assignee Lender complies, in all material respects, with the terms of the Loan Documents. 
 4.
LIMITATIONS OF LIABILITY 
 Neither Assignor Lender (except as provided in Section 3.2) nor Agent makes any representations or
warranties of any kind, nor assumes any responsibility or liability whatsoever, with regard to (a) the Loan Documents or any other document or instrument furnished pursuant thereto or the Loans, Letter of Credit Obligations or other
Obligations, (b) the creation, validity, genuineness, enforceability, sufficiency, value or collectibility of any of them, (c) the amount, value or existence of the Collateral, (d) the perfection or priority of any Lien upon the
Collateral, or (e) the financial condition of any Loan Party or other obligor or the performance or observance by any Loan Party of its obligations under any of the Loan Documents. Neither Assignor Lender nor Agent has or will have any duty,
either initially or on a continuing basis, to make any investigation, evaluation, appraisal of, or any responsibility or liability with respect to the accuracy or completeness of, any information provided to Assignee Lender which has been provided
to Assignor Lender or Agent by any Loan Party. Nothing in this Agreement or in the Loan Documents shall impose upon the Assignor Lender or Agent any fiduciary relationship in respect of the Assignee Lender. 

 5. FAILURE TO ENFORCE 
 No failure or delay on the part of Agent or Assignor Lender in the exercise of any power, right, or privilege hereunder or under any Loan Document will impair such power, right, or privilege or be construed to be a
waiver of any default or acquiescence therein. No single or partial exercise of any such power, right, or privilege will preclude further exercise thereof or of any other right, power, or privilege. All rights and remedies existing under this
Agreement are cumulative with, and not exclusive of, any rights or remedies otherwise available. 
 6. NOTICES 
 Unless otherwise specifically provided herein, any notice or other communication required or permitted to be given will be in writing and addressed to
the respective party as set forth below its signature hereunder, or to such other address as the party may designate in writing to the other. 
 7. AMENDMENTS AND WAIVERS 
 No amendment, modification, termination, or waiver of any provision of this Agreement will be effective
without the written concurrence of Assignor Lender, Agent and Assignee Lender. 
 8. SEVERABILITY 
 Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law. In the event
any provision of this Agreement is or is held to be invalid, illegal, or unenforceable under applicable law, such provision will be ineffective only to the extent of such invalidity, illegality, or unenforceability, without invalidating the
remainder of such provision or the remaining provisions of the Agreement. In addition, in the event any provision of or obligation under this Agreement is or is held to be invalid, illegal, or unenforceable in any jurisdiction, the validity,
legality, and enforceability of the remaining provisions or obligations in any other jurisdictions will not in any way be affected or impaired thereby. 
 9. SECTION TITLES 
 Section and Subsection titles in this Agreement are included for convenience of
reference only, do not constitute a part of this Agreement for any other purpose, and have no substantive effect. 
 10. SUCCESSORS AND
ASSIGNS 
 This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns.

 11. APPLICABLE LAW 
 THIS
AGREEMENT WILL BE CONSTRUED IN ACCORDANCE WITH AND GOVERNED BY THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO CONTRACTS MADE AND PERFORMED IN THAT STATE. 

 12. COUNTERPARTS 
 This Agreement and any amendments, waivers, consents, or supplements may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which, when so executed and
delivered, will be deemed an original and all of which shall together constitute one and the same instrument. 
 [Signature page follows]

 IN WITNESS WHEREOF, this Agreement has been duly executed as of the date first written above. 

 

									
	ASSIGNEE LENDER:	 		 	ASSIGNOR LENDER:
			
	FIFTH THIRD BANK, CHICAGO	 		 	FREEPORT LOAN FUND LLC
	(A MICHIGAN BANKING COMPANY)	 		 	
					
	By:	 	 	 		 	By:	 	 
	Title:	 	 	 		 	Title:	 	 
			
	Notice Address:	 		 	Notice Address:
			
	222 South Riverside Plaza	 		 	500 West Madison Street, Suite 7200
	33rd Floor, MD GRVR3I	 		 	Chicago, Illinois 60661
	Chicago, IL 60606	 		 	Attn: Addus HealthCare Inc. Account Officer
	Attn: Gregory H. Bork	 		 	Fax: (312) 281-4646
	Fax: (312) 704-4374	 		 	

 EXHIBIT B 
 CONSENT AND REAFFIRMATION (SEVENTH AMENDMENT) 
 Each of the undersigned (“Loan
Parties”) hereby (i) acknowledges receipt of a copy of the Consent and Seventh Amendment to Credit Agreement dated as of October 21, 2008 (the “Seventh Amendment”); (ii) consents to the execution and delivery
thereof by the other Loan Parties; (iii) agrees to be bound thereby; (iv) affirms that nothing contained therein shall modify in any respect whatsoever its guaranty of the obligations of the Loan Parties to Agent and Lenders (the
“Guarantee”) and (v) reaffirms that the Guarantee and the other Collateral Documents executed by such Person are and shall continue to remain in full force and effect. Although each of the Loan Parties has been informed of the
matters set forth herein and in the Seventh Amendment and has acknowledged and agreed to same, such Loan Parties understand that Agent and Lenders have no obligation to inform any of the Loan Parties of such matters in the future or to seek any of
the Loan Parties’ acknowledgment or agreement to future amendments or waivers, and nothing herein shall create such a duty. 
 This
Consent and Reaffirmation shall be governed by and construed in accordance with the laws of the State of Illinois, without reference to principles of conflicts of law. 

 In witness whereof, each of the undersigned has executed this Consent and Reaffirmation on and as of the
date of such Seventh Amendment. 
  

			
	ADDUS HOLDING CORPORATION
		
	By:	 	 
	Name:	 	Simon Bachleda
	Title:	 	Vice President and Secretary
	
	ADDUS HEALTHCARE, INC.
	
	ADDUS HEALTHCARE (NORTH CAROLINA), INC.
	
	ADDUS HEALTHCARE (IDAHO), INC.
	
	ADDUS HEALTHCARE (NEVADA), INC.
	
	ADDUS HEALTHCARE (NEW JERSEY), INC.
	
	FORT SMITH HOME HEALTH AGENCY, INC.
	
	LITTLE ROCK HOME HEALTH AGENCY, INC.
	
	LOWELL HOME HEALTH AGENCY, INC.
	
	PHC ACQUISITION CORPORATION
	
	PROFESSIONAL RELIABLE NURSING SERVICE, INC.
	
	BENEFITS ASSURANCE CO., INC.
		
	By:	 	 
	Name:	 	Frank Leonard
	Title:	 	SecretaryLicense Agreement, dated March 24, 2006

 Exhibit 10.17 
  

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

 LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS 
 AND SERVICES 
 THIS LICENSE AGREEMENT (“Agreement”), dated the
24th day of March, 2006 (the
“Effective Date”), by and between McKesson Information Solutions LLC (“McKesson”), with offices at 5995 Windward Parkway, Alpharetta, Georgia, 30005 and Addus HealthCare, Inc. (“Customer”) with offices at 2401
S. Plum Grove Road, Palatine, IL 60067. For all Software licensed under this License Agreement, the applicable Contract Supplement (“CS”) or Attachment shall specify: (i) the Software, (ii) the Equipment, (iii) the
Services, (iv) the Fees, and (v) the number of Concurrent Users, (vi) the Facility(ies), and (vii) such other mutually agreed upon information, if any. 
 1. LICENSE. 
 1.1 McKesson hereby grants to Customer and its wholly-owned subsidiaries a perpetual, non-exclusive,
non-transferable (except as set forth in Section 10.1) license to use the object code version of the Software on the Equipment located at Customer’s Facility (i) solely for the benefit of Permitted Users and (ii) if applicable,
by the number of Concurrent Users, regardless of location, provided that such access and use of the Software is relevant to the business relationship with Customer, and in a manner consistent with Customer’s own internal business purposes. In
this Agreement (a) “Documentation” means user guides and operating manuals, whether in print or machine-readable media, in effect as of the date of shipment; (b) “Facility” means the health facilities owned or operated
by or associated with Customer; (c) “Concurrent User” means a Permitted User identified by a unique user ID, issued by Customer, and who is one user out of a maximum number of users permitted to access the Software simultaneously;
(d) “Live Date” means the date that the Software is first used in an operational, non-test environment, utilizing actual patient data, unless said use is delayed at Customer’s request or through no fault of McKesson, in which
case the Live Date shall mean the date specified in the implementation workplan upon which said Software would have been available for use in a live, operational environment but for the delay; (e) “Software” means such computer
programs listed on a CS or Attachment and any updates, enhancements, modifications, versions, releases and upgrades thereto provided by McKesson under this Agreement; (f) “Permitted User” means, with respect to any Software identified
in a CS or Attachment, (i) any employee of Customer, (ii) any physician with patient admitting privileges at a Facility for which the Software is licensed, (iii) any employee of such physician, (iv) any medical professional who
is authorized to perform services for Customer at a Facility, and (v) any agent, student, volunteer or independent contractor of Customer to the extent that such persons need to use such Software in connection with Customer’s own internal
business purposes as permitted under this Agreement, and who are bound by confidentiality terms no less restrictive than those contained in Section 4.1 herein; and (g) “Equipment” means the computer equipment identified in a CS
or Attachment that Customer purchases from McKesson. 
 1.2 The Software may be transferred for up to thirty (30) days to a backup computer if the
Equipment is inoperative. Customer may make and use additional copies of Software and Documentation as reasonably necessary to use the Software and for testing, disaster recovery, back-up, or archival purposes. Customer shall not rent, lease or
provide remote computer services or distribute the Software, or permit the use of the Software by an outsource or facility management service to any third party, without the prior written consent of McKesson, which will not be unreasonably withheld.
McKesson’s consent will be deemed to be reasonably withheld, among other possible reasons, if (i) the third party makes commercially available products that are competitive with any McKesson products or (ii) the third party is an
entity or is affiliated with an entity that has previously violated McKesson’s nondisclosure agreement or shown similar disregard with respect to McKesson’s or McKesson’s affiliates’ intellectual property. The Software or
Documentation may not be copied or used other than as permitted by this Agreement. 
 1.3 As soon as practicable after signing the applicable CS or
Attachment, McKesson shall deliver the Software and one copy of Documentation to the designated site. Customer does not have a license to, and is not permitted to use in any way, any other McKesson software delivered to Customer by McKesson other
than the Software licensed under the applicable CS or Attachment. 
 1.4 Software Testing Period. Customer will have the right to test any Software
delivered by McKesson hereunder to ensure that it performs in all material respects in accordance with the applicable Documentation. Such testing will commence on the Software delivery date and will end sixty (60) days after the Live Date (the
“Software Testing Period”) unless, prior to the expiration of the Software Testing Period, Customer provides McKesson with a reasonably detailed written report that identifies any material nonconformities in the performance of the Software
from the Documentation (“Error Report”). In such event, the Software Testing Period will continue until McKesson corrects all nonconformities identified in an Error Report to the extent necessary in order for the Software to perform in all
material respects in accordance with the applicable Documentation. 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 2. SOFTWARE MAINTENANCE. 
 2.1 Software Maintenance Services (“Software Maintenance Services”) shall include, for the two (2) most current releases of the Software, corrections of Software or Documentation due to defects or errors in the Software or
Documentation, as applicable, and improvements to existing functionality provided by McKesson after the Software delivery date but not otherwise separately priced or marketed by McKesson. McKesson and Customer shall comply with McKesson’s
written Software Maintenance Services procedures as contained in the McKesson Support Manual incorporated herein by reference, as may be reasonably modified from time to time. In addition, McKesson shall provide the services set forth on a CS or
Attachment with respect to the particular Software licensed, if any. 
 2.2 McKesson shall provide, and Customer shall pay for, Software
Maintenance Services for a period of two (2) years (the “Initial Software Maintenance Term”), beginning upon execution of the applicable CS or Attachment, Software Maintenance Services Fees are set forth on the CS or Attachment and,
unless set forth otherwise in the applicable CS, shall be payable on a monthly basis on the first (1st) day of each calendar month and be pro-rated on a daily basis using a 365-day year. Unless set forth otherwise in the applicable CS, following the expiration of the Initial Software Maintenance Term, and subject
to Customer’s payment of the applicable Software Maintenance Services fees (except for any such fees that are the subject of a reasonable, good-faith dispute by Customer), McKesson will continue to provide Software Maintenance Services for
successive, automatically renewable one (1) year periods (“Renewal Terms”) unless either party provides the other party with written notice of termination of Software Maintenance Services no less than three (3) months prior to
the end of the Initial Software Maintenance Term or three (3) months prior to the end of the applicable Renewal Term. Notwithstanding the foregoing, McKesson may suspend Software Maintenance Services for nonpayment of any sums owed to McKesson
which are undisputed and ninety (90) days or more past due. McKesson may, effective one (1) year after execution of the applicable CS or Attachment and during any Renewal Term, increase the Annual Software Maintenance Services Fee for any
Software once a year by the lower of (a) four percent (4%), or (b) the annual percentage increase in the ECI Index for White Collar Workers. 
 3.
SOURCE CODE RIGHTS. 
 3.1 Source Code Escrow. As further described in the applicable CS, Customer shall be entitled, at its sole expense, to have the
source code for all licensed, Generally Available McKesson-owned Software escrowed with McKesson’s nationally recognized escrow agent. 
 3.2 Source
Code Release. During the Initial Software Maintenance Term and any applicable Renewal Term, McKesson agrees that in the event it (i) fails to cure a material breach of its Software Maintenance Services obligations hereunder or
(ii) discontinues Software Maintenance Services for the applicable Software for its customers in general, McKesson, upon Customer’s written request, shall deliver to Customer, for all Generally Available McKesson-owned Software, source
code and Documentation of every kind and nature necessary for Customer to operate said Software solely in accordance with the terms of this Agreement (“Released Source Code”). 
 3.3 Source Code License. If Customer obtains the Released Source Code in accordance with Section 3.2, then, subject to the terms and conditions of this Agreement, McKesson hereby grants Customer a
nonexclusive, nontransferable (except as provided in Section 10.1 of this Agreement), perpetual license to use and modify the Released Source Code for the sole purpose of correcting errors and bugs in the Software. Any such rights will be
limited to Individuals to whom access is necessary to accomplish said permitted use of the Released Source Code. 
 3.4 Confidential Treatment.
Customer will treat the Released Source Code as McKesson Confidential Information under Section 4 below, provided that McKesson may condition Customer’s continued use of the Released Source Code upon Customer’s agreement to comply
with, and actual compliance with, reasonable precautions specified by McKesson to avoid unauthorized use or disclosure of the Released Source Code. 
 4.
CONFIDENTIALITY. 
 4.1 Each party (the “Discloser”) may disclose to the other party (the “Recipient”) certain non-public information
relating to the Discloser’s business, including technical, marketing, financial, personnel, planning, medical records and other information that is marked confidential or which the Recipient should reasonably know to be confidential given the
nature of the information and the circumstance of disclosure (“Confidential Information”). Confidential Information of each party shall also include the terms of this Agreement and each CS, but not the existence and general nature of this
Agreement and each CS. Confidential Information will not include any Information: 
 
 (a) lawfully obtained or created by the Recipient independently of, and without use of, Discloser’s Confidential Information and without breach of any obligation of confidence; or 
 (b) that is in or enters the public domain without breach of any obligation of confidence. 

			
	 LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO
 MCKESSON INFORMATION SOLUTIONS LLC
	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 4.1.1 Except as expressly permitted by this Agreement, the Recipient will: 
 (a) not disclose Discloser’s Confidential Information except (i) to the employees or contractors of the Recipient to the extent that they need to know that
Confidential Information for the purpose of performing the Recipient’s obligations under this Agreement, and who are bound by confidentiality terms with respect to that Confidential Information no less restrictive than those contained in this
Section 4; or (ii) as required to be disclosed by law, to the extent required to comply with that legal obligation, provided that the Recipient will promptly notify the Discloser of such obligation; 
 (b) use the Discloser’s Confidential Information only for the purpose of performing Recipient’s obligations under this Agreement; and 
 (c) use all reasonable care in handling and securing the Discloser’s Confidential Information, and employ all reasonable data security measures that the Recipient
ordinarily uses with respect to its own proprietary information of similar nature and importance. 
 4.1.2 The Recipient will return to the Discloser, and
destroy or erase all of the Discloser’s Confidential Information in tangible form, upon the expiration or termination of this Agreement, and the Recipient will promptly certify in writing to the Discloser that it has done so. 
 4.2 McKesson agrees to the obligations set forth on Exhibit 1 attached hereto. 
 4.3 Customer may terminate the Agreement and any other agreement that requires the use of PHI if McKesson has violated a material term of Exhibit 1 to this Agreement and has failed to cure such breach within thirty (30) days after
Customer has provided McKesson with prompt written notice of such material breach. 
 5. PROPRIETARY RIGHTS. 
 5.1 All Software and Documentation, and any modifications or copies thereof, are proprietary and protected by copyright and/or trade secret law and no ownership rights
are transferred by this Agreement. All proprietary notices incorporated in, marked on, or affixed to a Software or other Confidential Information by McKesson or its suppliers shall be duplicated by Customer on all copies of all or any part of the
Software and shall not be altered, removed or obliterated. Customer shall not reverse reengineer, reverse assemble or reverse compile any Software or part thereof. All changes, modifications or improvements made or developed with regard to the
Software by McKesson shall remain the property of McKesson. 
 6. WARRANTY. 
 6.1 McKesson warrants that (a) so long as all undisputed Fees related to the Software have been paid in full when due, the Software (excluding any programming changes made by Customer), when operating on the
Equipment, will be capable of performing in all materials respects in accordance with all functional specifications set forth in the Documentation; and (b) as delivered to Customer, the Software does not contain any virus, worm, trap door, back
door, timer or other device that would interfere or disrupt the use of the Software in accordance with the Documentation or that would corrupt or erase any data. McKesson warrants that McKesson shall not insert any such devices into the Software and
McKesson shall use all reasonable practices and security measures necessary to prevent or avoid the insertion of such devices. In the event such device is found in the Software, McKesson will, at no charge, remove such device and repair any damage
caused thereby at the request of Customer, provided that if such device did not originate through a breach of the representation and warranties in this Section 6.1, or otherwise through McKesson, McKesson may invoice Customer for such services
at McKesson’s then-current rates. 
 6.2 Customer’s sole and exclusive remedy for breach of any of the foregoing warranties shall be either repair
or replacement of the defective materials; provided, however, that if McKesson does not repair or replace any such defective materials within a commercially reasonable time period, Customer may pursue any available remedies. 
 6.3 EXCEPT AS EXPRESSLY SET FORTH IN THIS AGREEMENT, MCKESSON MAKES NO OTHER WARRANTY OF ANY KIND WHATEVER, EXPRESS OR IMPLIED, AND ALL IMPLIED WARRANTIES OF
MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE ARE HEREBY DISCLAIMED BY MCKESSON AND EXCLUDED FROM THIS AGREEMENT. 
 7. INTELLECTUAL PROPERTY
INFRINGEMENT. 
 McKesson agrees to defend or settle at McKesson’s own expense any action or other proceeding asserted against Customer alleging that
any Software or Documentation infringes any U.S. copyright, trademark, patent or trade secret of a third-party, provided McKesson is given prompt written notice of, and full and complete authority, information and assistance (at McKesson’s sole
cost and expense) in the defense of, such claim, suit or proceeding. McKesson shall not be responsible for the cost of any settlement of any such claim, suit or proceeding made without the written consent of McKesson. In addition, and at the sole
option and expense of McKesson, McKesson may, at any time after any such claim has been asserted, and shall, in the event any Software is held to constitute an infringement, either procure for Customer the right to continue using that Software, or
replace or modify that Software so that it becomes non-infringing, provided that such replacement or modified Software has the same functional characteristics as the infringing Software, or, if the prior two remedies are commercially impractical in
McKesson’s 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 
reasonable opinion, then McKesson may take possession of the affected Software and terminate Customer’s rights and McKesson’s obligations under
this Agreement in respect of such Software, and upon any such termination refund to Customer a portion of the fees paid for that Software based upon a seven (7) year straight-line depreciation, with depreciation deemed to have commenced on the
corresponding Live Date, as well as all Implementation Services fees paid by Customer for the affected Software and a pro-rated portion of any pre-paid but unused Software Maintenance services fees for the affected Software, if any. Customer may
engage its own counsel, at its own expense, to advise Customer in connection with any such claim, suit or proceeding. McKesson shall not be liable to Customer under the terms of this Paragraph or otherwise if any infringement or claim (a) is
based upon the use of any Software in violation of this Agreement, or (b) is based upon the use of any Software in combination with any software other than programs licensed by McKesson to Customer for such use (and such infringement would not
have occurred but for such combination), or (c) arises solely from a Software customization performed by McKesson for Customer based upon Customer’s ideas, designs, or specifications (and such infringement would not have occurred but for
such customization). The foregoing provisions state McKesson’s sole and exclusive obligations and Customer’s sole and exclusive remedies with respect to Software and Documentation infringement. 
 8. LIMITATION OF LIABILITY. 
 8.1 Except as provided in Section 7,
MCKESSON’S TOTAL CUMULATIVE LIABILITY UNDER THIS AGREEMENT WITH RESPECT TO ANY SOFTWARE, EQUIPMENT OR SERVICES DELIVERED UNDER ANY CONTRACT SUPPLEMENT WILL BE LIMITED TO THE TOTAL FEES PAID (LESS ANY REFUNDS OR CREDITS) BY CUSTOMER TO MCKESSON
UNDER SUCH CONTRACT SUPPLEMENT. EXCEPT FOR (A) CUSTOMER’S PAYMENT OBLIGATIONS OR (B) LIABILITY ARISING FROM CLAIMS OF VIOLATION OF THE SCOPE OF USE OF THE LICENSE, CUSTOMER’S TOTAL CUMULATIVE LIABILITY UNDER THIS AGREEMENT WILL
BE LIMITED TO THE TOTAL FEES PAID AND PAYABLE BY CUSTOMER TO MCKESSON UNDER THE RELEVANT CONTRACT SUPPLEMENT (INCLUDING ALL FEES FOR SOFTWARE LICENSES, SOFTWARE MAINTENANCE SERVICES, AND IMPLEMENTATION AND EDUCATION AND RELATED SERVICES).

 8.2 IN NO EVENT WILL EITHER PARTY BE LIABLE TO THE OTHER PARTY UNDER, IN CONNECTION WITH, OR RELATED TO THIS AGREEMENT FOR ANY SPECIAL, INCIDENTAL,
INDIRECT OR CONSEQUENTIAL DAMAGES, WHETHER BASED ON BREACH OF CONTRACT, WARRANTY, TORT, PRODUCT LIABILITY, OR OTHERWISE, AND WHETHER OR NOT SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE. THE EXCLUSION OF DAMAGES IN THIS SECTION 8.2
WILL NOT APPLY TO (i) ANY LIABILITY OF MCKESSON UNDER SECTION 7 OR (ii) ANY LIABILITY OF CUSTOMER ARISING OUT OF OR RELATED TO INFRINGEMENT OF MCKESSON’S OR MCKESSON’S LICENSOR’S INTELLECTUAL PROPERTY OR VIOLATIONS OF THE
SCOPE OF THE USE OF THE LICENSE(S) GRANTED HEREUNDER. 
 8.3 THE PARTIES ACKNOWLEDGE AND AGREE THAT THE FOREGOING LIMITATIONS OF LIABILITY ARE A CONDITION
AND MATERIAL CONSIDERATION FOR THEIR ENTRY INTO THIS AGREEMENT. 
 9. EQUIPMENT 
 9.1 Purchase of Equipment 
 9.1.1 Agreement to Purchase and Sell. Subject to the terms and conditions of this
Agreement and each applicable CS (including without limitation payment of the applicable amounts pursuant to each applicable CS), McKesson agrees to sell to Customer, and Customer agrees to purchase from McKesson, the Equipment. 
 9.1.2 Third-Party Supply. Subject to the provisions of Section 1 governing the use of Software, Customer may acquire equipment to operate the Software
directly from a vendor other than McKesson (“Third-Party Vendor”), subject to the following conditions: 
 (a) Prior to acquiring any such
equipment from a Third-Party Vendor (“Third-Party Equipment”), Customer will: (i) obtain a price quotation from the Third-Party Vendor; (ii) permit McKesson to match the Third-Party Vendor’s quotation; and
(iii) purchase from McKesson corresponding equipment if McKesson offers Customer the same or better terms as the Third-Party Vendor’s quotation. 
 
 (b) If McKesson timely makes such an offer for corresponding equipment to Customer, then the parties will execute a CS under which Customer will purchase such equipment
from McKesson (in lieu of a Third-Party Vendor). 
 9.1.3 Certification of Third-Party Equipment. If Customer acquires any Third-Party Equipment upon
which it Intends to operate the Software, then prior to using it to operate the Software, Customer will either (i) make available such Third-Party Equipment to McKesson for testing and certification based on McKesson’s applicable hardware
specifications for operation of the Software and will pay McKesson the applicable equipment testing and certification fees and expenses, (ii) obtain McKesson’s written approval to use such 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 
Third-Party Equipment to operate the Software or (iii) certify to McKesson in writing that such Third-Party Equipment meets McKesson’s published
hardware specifications and minimum operating requirements or such other applicable hardware specifications and minimum operating requirements provided to Customer by McKesson in writing. If McKesson determines that the Third-Party Equipment
complies with such specifications, then McKesson will certify compliance to Customer. 
 9.2 Delivery, Installation and Configuration. 
 9.2.1 Equipment Delivery. Title and all risk of loss or damage to Equipment will pass to Customer upon shipment to Customer. Unless Customer clearly advises
McKesson to the contrary in writing, McKesson may make partial shipments of Equipment, to be separately invoiced and paid for when due. Delay in delivery of any installment will not relieve Customer of its obligation to accept the remaining
Equipment purchased under this Agreement. 
 9.2.2 Equipment Installation and Configuration. McKesson, by itself or using its third party suppliers,
will provide installation and configuration services for the Equipment, but specifically excluding peripherals, at the Facility. Customer will be responsible, at Customer’s sole expense, for preparing the Facility for installation of the
Equipment, including any necessary alterations to the Facility and any required cabling, and will provide McKesson with all assistance reasonably required by McKesson to perform such installation and configuration services. 
 9.3 Equipment Warranties. 
 9.3.1 McKesson Warranties.
McKesson warrants that, at the time of sale to Customer: (a) McKesson has power to convey title to the Equipment, free of any security interests, liens and encumbrances; and (b) the Equipment is new, unless the parties agree to the
contrary. 
 9.3.2 Third-Party Warranties and Licenses. To the extent that McKesson has the right to do so, McKesson hereby transfers and assigns to
Customer the benefit of, and Customer agrees to be bound by and comply with the provisions of: (a) any rights under any supplier’s warranty for the Equipment; and (b) any license or right to use the Equipment and any components of it
(such as embedded software). 
 9.4 Equipment Maintenance. 
 9.4.1 Equipment Maintenance Services. Subject to payment of the Equipment Maintenance Services fees set forth in the applicable CS in accordance with the terms of that CS, McKesson, by itself or using its third party suppliers, will
provide Equipment Maintenance Services to Customer for the Equipment. Equipment Maintenance Services fees for the Initial Equipment Maintenance Term (as defined in Section 9.4.2) will be payable as of the later of the date of McKesson’s
delivery of the Equipment to Customer (“Equipment Delivery Date”) or thirty (30) days prior to the date of expiration of the applicable McKesson Equipment supplier warranty. Thereafter, Equipment Maintenance Services fees will be
payable prior to the commencement of each one (1) month renewal period of Equipment Maintenance Services, as specified in Section 9.4.2. McKesson may increase the Equipment Maintenance Services fees by any price increase from
McKesson’s Equipment suppliers, effective as of the date of the suppliers’ price increase. 
 9.4.2 Equipment Maintenance Term. Except as
otherwise specified in a CS, McKesson will provide Equipment Maintenance Services for an initial term that will commence as of the later of the Effective Date of this Agreement or the effective date of the applicable CS and will end three
(3) years thereafter (the “Initial Equipment Maintenance Term”). Following the expiration of the Initial Equipment Maintenance Term, subject to Customer’s payment of the applicable Equipment Maintenance Services fees, McKesson
will continue to provide Customer with Equipment Maintenance Services for successive, automatically renewable one (1) month periods, unless either party provides the other party with written notice of termination of Equipment Maintenance
Services no less than one (1) month prior to the end of the Initial Equipment Maintenance Term or the end of the next renewal period. 
 
 10. GENERAL. 
 10.1 This Agreement will bind and inure to the benefit of
each party’s permitted successors and assigns. Except as otherwise expressly set forth below, Customer shall not assign this Agreement or any license granted hereunder without the express written consent of McKesson, which consent shall not be
unreasonably withheld or delayed. Customer may, upon notice to McKesson, assign this Agreement, together with any license granted hereunder, to any Affiliate or any entity resulting from the sale, combination or transfer of all or substantially all
of the assets or capital stock, or from any other corporate form of reorganization, provided the assignment is not to a competitor of McKesson. Upon any permitted assignment of this Agreement, Customer shall not incur any transfer fees other than
such fees as may be required for any expanded or additional licenses, equipment, or services necessary for as a result of such assignment. McKesson may, upon notice to Customer, assign this Agreement to any affiliate or any entity resulting from the
sale, combination or transfer of all or substantially all of the assets or capital stock, or from any other corporate form of reorganization by or of McKesson. McKesson may subcontract any of its obligations under this Agreement, and may perform
those obligations through personnel employed by, or under contract with, McKesson. 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 10.2 Audit. 
 10.2.1 McKesson may from time to time perform an audit to determine compliance with the terms of this Agreement upon reasonable notice. If the number of copies or users is found to be greater than that contracted for on any CS or
Attachment, McKesson may charge Customer the license fees per the Audit License Fee Schedule below for additional licenses required to bring Customer into license compliance as set forth on the applicable CS, regardless of any different pricing
commitments set forth in any CS. If the resulting adjustments to the license fees owing by Customer are greater than ten percent (10%) of the license fees previously paid by Customer to McKesson, McKesson may also charge Customer the reasonable
expenses associated with such audit. 
 10.2.2 In the event Customer must purchase additional Software licenses per this Section, Customer will purchase such
licenses for a license fee equal to the applicable percentage as shown below off of the then-current list price for such McKesson-owned Software (the “Discount”), pursuant to the terms and conditions of this Agreement, the execution of a
CS identifying such McKesson-owned Software, and subject to each of the following: (a) the Discount shall not apply to any Third-Party Software or Third-Party Software Maintenance Services and (b) as of the effective date of the applicable
CS, Customer is not past due on any undisputed invoices, fees, charges or expenses owed to McKesson. 
  

				
	 Audit License Fee Schedule
	  	 	 
		
	 Number of Years After Effective Date of this Agreement
	  	Discount	 
	 First 3 Years
	  	35	% 
	 Year 4
	  	30	% 
	 Year 5
	  	25	% 
	 Year 6
	  	17	% 
	 Thereafter
	  	List	  

 10.2.3 Any audit by McKesson pursuant to this Section shall comply with Customer’s reasonable privacy,
security, network and other applicable policies and procedures that are provided to McKesson in writing promptly following receipt of written notice from McKesson that an audit will be performed. 
 10.3 Payment Terms. 
 10.3.1 Customer will pay all fees and other
charges due under individual Contract Supplements to McKesson in United States dollars, as invoiced by McKesson within thirty-five (35) days after date of invoice to the Facility designated in writing by Customer. Such invoices may also
include, as applicable, packing, delivery and insurance charges incurred by McKesson or its suppliers in connection with delivering the Software and Equipment to Customer. Customer will also reimburse McKesson, within thirty-five (35) days
after date of invoice, for all reasonable out-of-pocket expenses incurred by McKesson or its suppliers in the course of providing services, including, but not limited to, travel, accommodations and living expenses in accordance with McKesson’s
then-current travel policies; McKesson’s current travel policies as of the Effective Date are set forth in Exhibit 2 hereto. However, if Customer does not pay such fees, charges or expenses when due, then McKesson reserves the right to require
reasonable advance payments or credit arrangements through a third party as a condition to providing Software, Equipment or Services, as the case may be, notwithstanding any express obligation to provide them elsewhere in this Agreement. Disputes as
to the accuracy of an invoice must be presented in writing to McKesson by Customer within sixty-five (65) days of the date of the invoice, and such disputes will be addressed by the parties in accordance with Section 10.13 of this
Agreement. Notwithstanding the foregoing, unless otherwise stipulated herein, failure by Customer to make payments to McKesson which are reasonably disputed in writing in accordance with this paragraph and Section 10.13 herein, and for which
resolution is promptly commenced, shall not constitute a material breach of this Agreement, and McKesson shall continue to provide services during any such dispute. 
 10.3.2 McKesson may charge Customer interest on the outstanding balance of any overdue fees, charges or expenses at a rate equal to one percent (1%) per month or the highest rate permitted by applicable law,
whichever is lower. Notwithstanding the foregoing, McKesson will charge said interest only on undisputed invoices, fees, charges or expenses, provided that Customer has provided notice of such dispute in accordance with Section 10.3.1 above and
the dispute is alleged by Customer in good faith. Customer will reimburse McKesson for all reasonable costs and expenses incurred (including reasonable attorneys’ fees) in collecting any overdue amounts. 
 10.4 Within ninety (90) days of termination of any license granted pursuant to this Agreement, Customer shall cease using the Software and Documentation and
Customer shall certify to McKesson in writing that all copies (in any form or media) of the Software and Documentation, whether or not modified or incorporated into other materials, have been destroyed or returned to McKesson. Termination of this
Agreement or any license shall not relieve Customer’s obligation to pay all fees incurred prior to such termination, except any such fees that are the subject of a reasonable, good-faith dispute by Customer, and shall not limit either party
from pursuing any other remedies available to it. Each party’s obligations under Section 4 hereof shall survive termination of any license or this Agreement. 
 10.5 Third-party Software (“Third-Party Software”) sublicensed or distributed by McKesson to Customer, if any, is identified on the applicable CS or Attachment. To the extent that the terms or conditions
under which McKesson sublicenses or distributes any such software to Customer differ from the terms and conditions otherwise stated in this 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 
Agreement, said differences are stated on such CS or Attachment or in shrinkwrap agreements provided with such software and such differences shall control;
provided, however, that if Customer has a reasonable objection to any such differences in such a shrinkwrap agreement, the parties shall negotiate in good faith any commercially reasonable and practical remedy. In the event that McKesson can
reasonably demonstrate the need to replace or substitute any Third-Party Software, the parties agree to negotiate in good faith the terms and conditions under which McKesson will make available reasonably comparable software for the originally
licensed Third-Party Software. 
 10.6 This Agreement is subject to any governmental laws, orders or other restrictions on the export of Software and related
information and Documentation that may be imposed by governmental authorities. Customer shall comply with any governmental laws, orders or other restrictions on the export and re-export of Software (including technical data and any related
information and Documentation) which may be imposed from time to time by the governments of the United States and any country to which any Software is shipped. 
 10.7 A Party may terminate this Agreement or any C S immediately upon notice to the other party if the other party: (a) materially breaches this Agreement or the applicable Contract Supplement and fails to remedy that breach within
sixty (60) days after receiving notice of the breach, provided that if a longer period is reasonably required to cure the breach and the cure is promptly begun, such cure period shall be extended for as long as the cure is being diligently
prosecuted to completion; (b) infringes the intellectual property rights and fails to remedy that breach within thirty (30) days after receiving notice of the breach; (c) materially breaches this Agreement or the applicable C S in a
manner that cannot be remedied; or (d) commences dissolution proceedings or ceases to operate in the ordinary course of business. Material breach of a particular C S does not allow the terminating party to terminate this Agreement in its
entirety or any other C S unless the terminating party’s rights under this Agreement or such other C S are substantially diminished by the breach. All notices relating to termination or default under this Agreement shall be in writing and
delivered by overnight delivery service or certified mail return receipt requested, to the address of such party specified above (addressed in the case of McKesson to the attention of its General Counsel) or specified by such party in accordance
with this Section. 
 10.8 McKesson and Customer agree to make available upon the written request of the Secretary of Health and Human Services or the
Comptroller General, or their representatives, this Agreement and such books, documents and records as may be necessary to verify the nature and extent of the costs of the services rendered hereunder to the full extent required by the Centers for
Medicare & Medicaid Services implementing Section 952 of the Omnibus Reconciliation Act of 1980, codified at 42 U.S.C. Section 1395x(v)(1)(I), or by any other applicable federal or state authority. 
 10.9 This Agreement shall be governed by and construed in accordance with the laws in the state in which the Customer is located, exclusive of its rules governing choice
of law and conflict of laws. 
 10.10 Any action of any kind arising out of or in any way connected with this Agreement, other than collection of outstanding
payment obligations, must be commenced within two (2) years of the date upon which the cause of action was discovered or should reasonably have been discovered by the party bringing the action. 
 10.11 This Agreement, including exhibits, attachments, written terms incorporated by reference and Contract Supplements or Attachments, is the complete and exclusive
agreement between the parties with respect to the subject matter hereof, superceding and replacing all prior agreements, communications, understandings (both written and oral) regarding such subject matter. Pre-printed terms and conditions on or
attached to Customer’s purchase orders shall be of no force or effect. Each party executes this Agreement by its duly authorized representative. 
 10.12 Nothing in this Agreement shall confer upon any person other than the Parties and their respective successors or assigns, any rights, remedies, obligations, or liabilities whatsoever. 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 10.13 Dispute Resolution. Any claim arising out of or relating to this Agreement or its subject matter or any
right or obligation created by this Agreement, irrespective of the legal theory or claims underlying such dispute (including tort or statutory claims) (“Dispute”) shall be resolved in accordance with this Section 10.13. The party
asserting the Dispute will give prompt notice to the other party describing the Dispute in reasonable detail (“Dispute Notice”). Each party agrees not to commence court proceedings against the other party relating to a Dispute except as
expressly permitted by the terms of this Section 10.13, after complying with the escalation procedures and forty (40) day internal negotiation requirements stated herein, except that the provisions of this Section will not prevent a party
from commencing court proceedings seeking injunctive relief for Disputes related to Intellectual Property Rights. Promptly after receipt of the Dispute Notice, the parties will negotiate in good faith to resolve the Dispute. Either party may
escalate the Dispute negotiations to higher level personnel, by notice to the other party, as specified below: 
  

					
	 Customer
	  	 McKesson
	  	 Time After Dispute Notice

		  	Project Manager/Account Executive	  	Immediate
			
		  	Senior Customer Services, Software Business Unit	  	15 days
			
		  	Vice President, Software Business Unit	  	25 days

 If the Dispute has not been resolved within forty (40) days after receipt of the Dispute Notice, then either
party may commence court proceedings against the other party. 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date set forth above.

  

											
	ADDUS HEALTHCARE, INC.	 		 	MCKESSON INFORMATION SOLUTIONS LLC
						
	By:	 	 /s/ W. Andrew Wright
	 		 	By	 	  
	 	
	Name Printed:	 	 W. Andrew Wright
	 		 	Name Printed:	 	  
	 	
	Title:	 	 President and CEO
	 		 	Title:	 	  
	 	
	Date:	 	 3/24/06
	 		 	Date:	 	  
	 	

  

 Page 9 of 15 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 EXHIBIT 1 
 MCKESSON BUSINESS ASSOCIATE AGREEMENT EXHIBIT 
 1. DEFINITIONS. All capitalized terms used herein that are not
otherwise defined have the meanings ascribed in HIPAA. 
 1.1 “Designated Record Set” means a group of records maintained by or for Customer that
are the medical records and/or billing records of individual patients or are otherwise used by Customer to make decisions about individual patients. 
 1 2
“HIPAA” means the Health Insurance Portability and Accountability Act of 1996 and the federal HIPAA privacy regulations at 45 C.F.R. parts 160 and 164. 
 1 3. “Individually Identifiable Health Information” means individually identifiable health information as defined at 45 C.F.R. § 164.501. 
 1.4. “Protected Health Information” or “PHI” means Individually Identifiable Health Information (transmitted or maintained in any form or medium) concerning Customer patients or the patients of any of Customer’s
health care provider customers. 
 2. RESPONSIBILITIES OF THE PARTIES WITH RESPECT TO PROTECTED HEALTH INFORMATION. 
 2.1 Responsibilities of McKesson. Beginning upon the compliance date established by HIPAA, with regard to PHI obtained from Customer, McKesson agrees as follows:

 (a) McKesson will use and/or disclose the PHI only as permitted or required by the Agreement or as required by law. 
 (b) McKesson will use appropriate safeguards to maintain the security of the PHI and to prevent unauthorized use or disclosure of PHI, which will in no event be any less
than the means which McKesson uses to protect its own confidential information. 
 (c) McKesson will promptly report to Customer any use or disclosure of PHI
of which McKesson becomes aware that is not permitted by this Exhibit. 
 (d) If McKesson is permitted to utilize an agent or subcontractor to perform any of
its obligations under the Agreement, McKesson will require all such subcontractors and agents that receive or use, or have access to, PHI under the Agreement to agree, in writing, to the same restrictions and conditions on the use and/or disclosure
of PHI that apply to McKesson pursuant to this Exhibit. 
 (e) McKesson will make available its internal practices, books and records relating to the use and
disclosure of PHI to the Secretary of HHS for purposes of determining Customer’s compliance with HIPAA. 
 (f) McKesson will provide to Customer such
information in McKesson’s possession as is reasonably requested by Customer and necessary to enable Customer to respond to a request by an individual for an accounting of the disclosures of the individual’s PHI in accordance with HIPAA.

 (g) Unless otherwise explicitly stated in the applicable Contract Supplement, the parties do not intend for McKesson to maintain any PHI in a Designated
Record Set for Customer. If McKesson maintains any PHI in a Designated Record Set, then McKesson agrees to (1) provide to Customer such PHI in a timely fashion upon written request, and (2) to make amendments to such PHI in accordance with
HIPAA. 
 (h) If McKesson believes it has a legal obligation to disclose any PHI, it will notify Customer as soon as reasonably practical after it learns of
such obligation, and in any event within a time sufficiently in advance of the proposed release date such that Customer’s rights would not be prejudiced, as to the legal requirement pursuant to which it believes the PHI must be released. If
Customer objects to the release of such PHI, McKesson will allow Customer to exercise any legal rights or remedies McKesson night have to object to the release of the PHI, and McKesson agrees to provide such assistance to Customer, at
Customer’s expense, as Customer may reasonably request in connection therewith. 
 (i) As of the final compliance date established by the applicable
regulation: 
 a. McKesson will implement administrative, physical, and technical safeguards that reasonably and appropriately protect the
confidentiality, integrity, and availability of the 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 
electronic protected health information that it creates, receives, maintains, or transmits on behalf of Customer as required by HIPAA. 
 b. McKesson will ensure that any agent, including a subcontractor, to whom it provides such information, agrees to implement reasonable and appropriate
safeguards to protect it. 
 c. McKesson will report to Customer any security incident of which it becomes aware. 
 2.2. Responsibilities of Customer. Customer agrees to obtain any consent or authorization that may be required by HIPAA, or applicable state law, prior to furnishing
McKesson with PHI. Customer agrees to timely notify McKesson, in writing, of any arrangements between Customer and the individual that is the subject of PHI that may impact in any manner the use and/or disclosure of that PHI by McKesson under this
Exhibit. 
 2.3. Effect of Changes of HIPAA Privacy Regulation on Responsibilities of the Parties. To the extent that any relevant provision of HIPAA is
materially amended in a manner that changes the obligations of McKesson or Covered Entities that are embodied in term(s) of this Exhibit, the Parties agree to negotiate in good faith appropriate non-financial terms or amendment(s) to this Exhibit to
give effect to such revised obligations. In addition, the terms of this Exhibit should be construed in light of any interpretation and/or guidance on HIPAA issued by HHS from time to time. 
 3. PERMITTED USES AND DISCLOSURES OF PROTECTED HEALTH INFORMATION BY MCKESSON. Except as specified below, McKesson may only access, duplicate or otherwise use or
disclose PHI as necessary to perform its obligations under the Agreement, provided that such use or disclosure would not violate HIPAA if done by Customer. Unless otherwise permitted by this Agreement, McKesson will not permit the disclosure of any
PHI to any person or entity other than such of its employees, agents or subcontractors who must have access to the PHI in order for McKesson to perform its obligations under the Agreement and who agree to keep such PHI confidential as required by
this Exhibit. Unless otherwise limited herein, McKesson may: 
 (a) use the PHI in its possession for its proper management and administration and to fulfill
any legal responsibilities of McKesson. 
 (b) disclose the PHI in its possession to a third party for the purpose of McKesson’s proper management and
administration or to fulfill any legal responsibilities of McKesson, provided that (i) the disclosures are required by law, or (ii) McKesson has received from the third party reasonable assurances regarding the confidential handling of
such PHI as required under HIPAA. 
 (c) aggregate the PHI obtained by McKesson. 
 4. TERMINATION OF AGREEMENT. 
 4.1. Termination by Customer. Customer may terminate this Agreement or any other agreement
that requires the use of PHI if McKesson has violated a material term of this Exhibit and has failed to cure such breach within thirty (30) days after Customer has provided McKesson with prompt written notice of such material breach.

 4.2. Return of PHI. Upon the expiration or termination, for any reason, of this Agreement that requires the use of PHI by McKesson. McKesson will promptly
return to Customer, or at Customer’s sole option destroy, any PHI in its possession or control and will retain no copies of such PHI, and, unless otherwise expressly agreed to in writing, any right or license which McKesson has to use the PHI
will terminate immediately upon such expiration or termination of this Agreement. If the destruction or return of the PHI is not reasonably feasible, the protections contained in this Agreement will continue to apply to any retained PHI, and any
further use or disclosure of the PHI by McKesson is limited solely to those purposes that made the return or destruction of such PHI infeasible. 
 5. RIGHT
TO INJUNCTIVE RELIEF. McKesson expressly acknowledges and agrees that the breach, or threatened breach, by it of any provision of this Exhibit may cause Customer to be irreparably harmed and that Customer may not have an adequate remedy at law.
Therefore, McKesson agrees that upon such breach, or threatened breach, Customer will be entitled to seek injunctive relief to prevent McKesson from commencing or continuing any action constituting such breach without having to post a bond or other
security and without having to prove the inadequacy of any other available remedies. Nothing in this paragraph will be deemed to limit or abridge any other remedy available to Customer at law or in equity. 
 6. MISCELLANEOUS. 
 6.1 Amendment to Comply with Law. The parties
acknowledge that state and federal laws relating to electronic data security and privacy are 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 
rapidly evolving and that amendment of this Agreement may be required to provide for procedures to ensure compliance with such developments. The parties
specifically agree to take such action as is necessary to implement the standards and requirements of HIPAA and other applicable laws relating to the security or confidentiality of Health Information. The parties understand and agree that Customer
must receive satisfactory written assurance from McKesson that McKesson will adequately safeguard all Health Information that it receives or creates on behalf of Customer Upon Customer’s request, McKesson agrees to promptly enter into
negotiations with Customer, concerning the terms of any amendment to this Agreement embodying written assurances consistent with the standards and requirements of HIPAA or other applicable laws. 
 6.2 Relationship to Underlying Agreement(s) Provisions. In the event that a provision of this Agreement is contrary to a provision of an underlying agreement(s), the
provision of this Agreement shall control. Otherwise, this Agreement shall be construed under, and in accordance with, the terms of such underlying agreement(s), and shall be considered an amendment of and supplement to such underlying agreement(s).

 6.3 Modification of Agreement. No alteration, amendment, or modification of the terms of this Agreement shall be valid or effective unless in writing and
signed by McKesson and Customer. 
 6.4 Non-Waiver. A failure of any party to enforce at any time any term, provision or condition of this Agreement, or to
exercise any right or option herein, shall in no way operate as a waiver thereof, nor shall any single or partial exercise preclude any other right or option herein. In no way whatsoever shall a waiver of any term, provision or condition of this
Agreement be valid unless in writing, signed by the waiving party, and only to the extent set forth in such writing. 
 6.5 Agreement Drafted By All Parties.
This Agreement is the result of arm’s length negotiations between the parties and shall be construed to have been drafted by all parties such that any ambiguities in this Agreement shall not be construed against either party. 
 6.6 Severability. If any provision of this Agreement is found to be invalid or unenforceable by any court, such provision shall be ineffective only to the extent that it
is in contravention of applicable laws without invalidating the remaining provisions hereof. 
 6.7 Section Headings. The section headings contained herein
are for convenience in reference and are not intended to define or limit the scope of any provision of this Agreement. 
 6.8 No Third Party Beneficiaries.
There are no third party beneficiaries to this Agreement. 
 6.9 Notices. Any notices required or permitted to be given hereunder by either party to the
other shall be given in writing: (1) by personal delivery; (2) by electronic facsimile with confirmation sent by United States first class registered or certified mail, postage prepaid, return receipt requested; (3) by bonded courier
or by a nationally recognized overnight delivery service; or (4) by United States first class registered or certified mail, postage prepaid, return receipt requested, in each case, addressed to 
 If to McKesson: 
 5995 Windward Parkway

 Alpharetta, Georgia 30005 
 Attn: General Counsel 
 If to Customer: 
 Addus HealthCare, Inc. 
 2401 S. Plum Grove Road 
 Palatine, Illinois 60067 
 Attn: Privacy
Officer 
 or to such other addresses as the parties may request in writing by notice given pursuant to this section 6.9. Notices shall be deemed received on
the earliest of personal delivery, upon delivery by electronic facsimile with confirmation from the transmitting machine that the transmission was completed; twenty-four (24) hours following deposit with a bonded courier or overnight delivery
service; or seventy-two (72) hours following deposit in the U.S. Mail as required herein. 
 6.11 Applicable Law and Venue. This Agreement shall be
governed by and construed in accordance with the internal laws of the State of Illinois (without regard to principles of conflicts of laws). The parties agree that all actions or proceedings arising in connection with this Agreement shall be tried
and litigated exclusively in the state or federal (if permitted by law and a party elects to file an action in federal court) courts located in Illinois. This choice of venue is intended by the parties to be mandatory and not permissive in nature,
and to preclude the 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 
possibility of litigation between the parties with respect to, or arising out of, this Agreement in any jurisdiction other than that specified in this
section 6.11. Each party waives any right it may have to assert the doctrine of forum non conveniens or similar doctrine or to object to venue with respect to any proceeding brought in accordance with this section 6.11. 
 6.12 Interpretation. Any ambiguity in this Agreement shall be resolved to permit compliance with the Privacy Regulations. 
 6.13. Survival. This Exhibit 1 will survive the termination or expiration of the underlying agreement. 
 (remainder of page intentionally left blank) 

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 EXHIBIT 2 
 2006 MCKESSON CORPORATE TRAVEL POLICY 
 TRAVEL POLICY, PROCEDURES, AND EXPENSE REIMBURSEMENT
GUIDELINES 
 I TRAVEL ARRANGEMENTS. All travel arrangements (to include airline, lodging, rental car, etc.) must be arranged through McKesson’s
currently designated corporate travel agency (“Agency”). Tickets not issued by the Agency will not be reimbursed. 
 A. Air Travel. The Company
will reimburse all business air travel as long as such travel is at the lowest cost available airfare, short of endangering the reason for the trip or the business needs dictated by a customer. The guidelines surrounding our travel policy are as
follows: 
 The lowest available airfare, regardless of penalties or restriction, must be utilized by anyone traveling at the expense of McKesson. Any
tickets being requested within 7-days of travel require Senior V.P. approval before the ticket can be issued by the Travel Department. 
 The Agency will
automatically confirm the lowest airfare available on the requested routing. The Agency will check all flights one and a half hours before and one and a half hours after the originally requested arrival, for the lowest available airfare and advise
the traveler of the lowest fare options. 
 B. Lodging. The Company will pay only actual room rental costs supported by the hotel bill for each day that
lodging away from home is required for business reasons. Hereafter, the standard hotel will be Marriott Courtyard-type lodging for all business-related travel. 
 C. Car Rentals. The Company will reimburse car rentals only when other means of transportation are unavailable, more costly, or impractical. The use of a rental car must be justified as a business need and not as a matter of personal
convenience. The use of intermediate or full-size cars is acceptable only when two or more employees are traveling together and sharing the rental car, or when it is necessary to have a larger vehicle for carrying clients or equipment. 

D. Other Transportation. 
 1. Personal Car. The Company prefers travel
through use of public transportation, but an employee’s automobile should be used when other transportation is unavailable or economy can be realized. The Company will reimburse the employee at the rate of $0.445 per mile over and above the
normal commute, plus parking and tolls, for authorized business use of personal cars. The normal commute includes an employee’s drive to his/her office, or FM site, if located in the same city in which the employee resides. 
 2. Taxis and Other Out-of-Town Transportation. The cost of a taxi to and from places of business, hotels, or airports in connection with business activities is
reimbursable. Use of taxis is authorized only when more economical services (hotel vans, shuttles, etc.) are not available. Employees are encouraged to utilize public transportation whenever feasible. Receipts are required for all transportation
expenses. 
 II. MEALS. The Company will reimburse employees for meal expenses (breakfast, lunch, and dinner) actually incurred, providing such expenses are
reasonable and appropriate. The suggested costs below should provide a guideline to employees as to what the Company feels is fair and reasonable, but in no event should the total exceed $40.00 per day: 
  

				
	 Breakfast
	  	$	 8.00
	 Lunch
	  	$	1200
	 Dinner
	  	$	20.00

			
	LICENSE AGREEMENT FOR HORIZON HOMECARETM SOFTWARE AND PURCHASE OF RELATED PRODUCTS AND SERVICES PROPRIETARY AND CONFIDENTIAL TO MCKESSON INFORMATION SOLUTIONS LLC	  	 Addus HealthCare, Inc.
 Customer No: TBD
 Contract No C0608555
 March 24, 2006

  

 III. OTHER REIMBURSABLE EXPENSES 
 A. Telephone Expenses. 
 1. Business. The Company will pay charges for local and long-distance business calls made outside a
Company office, provided the calls are supported by a listing hotel bill, or telephone bill. All domestic long distance telephone calls should be placed through AT&T. 
 2. Personal. The Company will pay charges for personal long distance calls when the employee is away from home for business reasons. These should be limited to one ten-minute call a day. In order to maximize the
savings potential employees should place personal calls through AT&T. 
 B. Laundry Expenses The Company will pay for reasonable laundry or dry cleaning
charges for employees who are traveling out of town and will be out of town on company business for five nights or more. In such situations, the employee’s manager determines the fair and reasonable nature and amount of reimbursable business
expenditure 
 C. Tips and Gratuities. The Company will pay for reasonable tipping and gratuities: 
  

	*	up to 20% of the total restaurant bill 

  

	*	$1 per bag porterage 

  

	*	up to 15% of the total cab fare 

 D. In-Town Expenses. When traveling
within his/her headquarters city, an employee may expense charges for local transportation if required for business purposes and when authorized. Whenever public transportation is not used, claims for taxis, private limousines, and personal car
mileage should be separated, claimed, and explained, showing the purpose of the trip and the itinerary.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00162-of-00352.parquet"}]]